Sign In
Buy ORGO
$2.33
+0.0900 (+4.02%)
At Close: Jun 03, 2026
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019
11:30am, Tuesday, 17'th Sep 2019
Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical
Largest Insider Trades of the Week
08:06pm, Friday, 06'th Sep 2019
Insiders dump shares of Facebook, Snap Continue reading...
MEDIA ALERT: Organogenesis Holdings Inc. (Nasdaq: ORGO) to Ring the Nasdaq Stock Market Closing Bell
01:00pm, Friday, 06'th Sep 2019
NEW YORK, Sept. 06, 2019 -- What:Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company, will visit the Nasdaq MarketSite in Times Square. In.
How does Tom Brady keep winning Super Bowls? It might have more to do with his brain than you think
07:22pm, Monday, 04'th Feb 2019
Every day, Tom Brady powers through over two dozen brain games that he claims helps him sharpen everything from his attention and brain speed to his memory and emotional intelligence.
2nd International Translational and Regenerative Medicine Conference -
12:50pm, Tuesday, 11'th Sep 2018
ITMC-2019 Conference Valencia, Spain
